Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|February 4, 2015
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenibMassimo Iavarone, Giuseppe Cabibbo, Marco Biolato, et al.
United European Gastroenterology Journal|September 20, 2018
Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatmentGiulio Antonelli, Elia Gigante, Massimo Iavarone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2019
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapyAlessandro Loglio, Massimo Iavarone, Mauro Viganò, et al.
Annals of Hepatology|May 1, 2019
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillanceMassimo Iavarone, Mauro Viganò, Nicole Piazza, et al.
European Journal of Immunology|November 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinomaLaura Gramantieri, Fabrizia Suzzi, Cristian Bassi, et al.
Hepatology Communications|July 14, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinomaMassimo Iavarone, Eleonora Alimenti, Lorenzo Canova, et al.
Cancers|March 13, 2024
Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on OutcomesEloisa Franchi, Daniele Eliseo Dondossola, Giulia Maria Francesca Marini, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) GuidancePierpaolo Biondetti, Anna Maria Ierardi, Elena Casiraghi, et al.
Technology in Cancer Research & Treatment|August 23, 2023
Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver TumorsAntonio Arrichiello, Anna Maria Ierardi, Alessandro Caruso, et al.
Journal of Hepatology|June 24, 2015
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort studyPietro Lampertico, Federica Invernizzi, Mauro Viganò, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|February 4, 2015
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenibMassimo Iavarone, Giuseppe Cabibbo, Marco Biolato, et al.
United European Gastroenterology Journal|September 20, 2018
Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatmentGiulio Antonelli, Elia Gigante, Massimo Iavarone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2019
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapyAlessandro Loglio, Massimo Iavarone, Mauro Viganò, et al.
Annals of Hepatology|May 1, 2019
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillanceMassimo Iavarone, Mauro Viganò, Nicole Piazza, et al.
European Journal of Immunology|November 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinomaLaura Gramantieri, Fabrizia Suzzi, Cristian Bassi, et al.
Hepatology Communications|July 14, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinomaMassimo Iavarone, Eleonora Alimenti, Lorenzo Canova, et al.
Cancers|March 13, 2024
Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on OutcomesEloisa Franchi, Daniele Eliseo Dondossola, Giulia Maria Francesca Marini, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) GuidancePierpaolo Biondetti, Anna Maria Ierardi, Elena Casiraghi, et al.
Technology in Cancer Research & Treatment|August 23, 2023
Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver TumorsAntonio Arrichiello, Anna Maria Ierardi, Alessandro Caruso, et al.
Journal of Hepatology|June 24, 2015
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort studyPietro Lampertico, Federica Invernizzi, Mauro Viganò, et al.
Pageof 15